- Home
- BHST vs AVTX Comparison
BHST vs AVTX Comparison
Compare BHST & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- AVTX
- Stock Information
- Founded
- BHST N/A
- AVTX 2011
- Country
- BHST Canada
- AVTX United States
- Employees
- BHST N/A
- AVTX N/A
- Industry
- BHST
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BHST
- AVTX Health Care
- Exchange
- BHST Nasdaq
- AVTX Nasdaq
- Market Cap
- BHST 104.0M
- AVTX 90.9M
- IPO Year
- BHST N/A
- AVTX 2015
- Fundamental
- Price
- BHST $6.30
- AVTX $11.50
- Analyst Decision
- BHST
- AVTX Buy
- Analyst Count
- BHST 0
- AVTX 2
- Target Price
- BHST N/A
- AVTX $35.00
- AVG Volume (30 Days)
- BHST N/A
- AVTX 64.4K
- Earning Date
- BHST N/A
- AVTX 11-07-2024
- Dividend Yield
- BHST N/A
- AVTX N/A
- EPS Growth
- BHST N/A
- AVTX N/A
- EPS
- BHST N/A
- AVTX N/A
- Revenue
- BHST N/A
- AVTX $820,000.00
- Revenue This Year
- BHST N/A
- AVTX N/A
- Revenue Next Year
- BHST N/A
- AVTX N/A
- P/E Ratio
- BHST N/A
- AVTX N/A
- Revenue Growth
- BHST N/A
- AVTX N/A
- 52 Week Low
- BHST N/A
- AVTX $3.95
- 52 Week High
- BHST N/A
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- AVTX 44.05
- Support Level
- BHST N/A
- AVTX $12.00
- Resistance Level
- BHST N/A
- AVTX $13.59
- Average True Range (ATR)
- BHST 0.00
- AVTX 0.95
- MACD
- BHST 0.00
- AVTX -0.26
- Stochastic Oscillator
- BHST 0.00
- AVTX 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).